Synonyms:
871
Status: Phase 3
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: VE267FC2UB

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Insulin-like growth factor I receptor antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Carcinoma, Large Cell 3 D018287 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Prostatic Neoplasms 2 D011471 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Head and Neck Neoplasms 2 D006258 ClinicalTrials
Lung Neoplasms 1 D008175 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials
Sarcoma 1 D012509 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Sarcoma, Ewing 1 D012512 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1743019
FDA SRS VE267FC2UB